• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

SAB——一种有望提高老年急性髓系白血病缓解率的新疗法？

SAB--a promising new treatment to improve remission rates in AML in the elderly?

作者信息

Wheatley Keith

机构信息

University of Birmingham Clinical Trials Unit, Park Grange, 1 Somerset Road, Edgbaston, Birmingham B15 2RR, UK.

出版信息

Br J Haematol. 2002 Aug;118(2):432-3. doi: 10.1046/j.1365-2141.2002.03620.x.

DOI:10.1046/j.1365-2141.2002.03620.x
PMID:12139727
Abstract

This short report presents the results of a comparison of complete remission rates and reasons for failure, between two series of patients aged 60 years or over with acute myeloid leukaemia (AML), and discusses their interpretation.

摘要

本简短报告展示了两组60岁及以上急性髓系白血病（AML）患者完全缓解率及失败原因的比较结果，并对其解读进行了讨论。

相似文献

1
SAB--a promising new treatment to improve remission rates in AML in the elderly?SAB——一种有望提高老年急性髓系白血病缓解率的新疗法？
Br J Haematol. 2002 Aug;118(2):432-3. doi: 10.1046/j.1365-2141.2002.03620.x.
2
Improved cure rate by very early intensification combined with prolonged maintenance chemotherapy in patients with acute myeloid leukemia: data from the AML Cooperative Group.急性髓系白血病患者采用极早期强化联合延长维持化疗提高治愈率：来自急性髓系白血病协作组的数据
Semin Hematol. 1991 Jul;28(3 Suppl 4):76-9.
3
Oral induction and consolidation of acute myeloid leukemia with etoposide, 6-thioguanine, and idarubicin (ETI) in elderly patients: a randomized comparison with 5-day TAD. Finnish Leukemia Group.依托泊苷、6-硫鸟嘌呤和伊达比星（ETI）口服诱导及巩固治疗老年急性髓系白血病：与5天TAD方案的随机对照研究。芬兰白血病研究组
Leukemia. 1994 Jan;8(1):11-5.
4
Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the Medical Research Council's 10th AML trial (MRC AML10). Adult and Childhood Leukaemia Working Parties of the Medical Research Council.急性髓系白血病儿童和年轻成人中柔红霉素阿糖胞苷（DAT）与阿糖胞苷柔红霉素依托泊苷（ADE）诱导化疗的随机对照比较。医学研究委员会第10次急性髓系白血病试验（MRC AML10）结果。医学研究委员会成人与儿童白血病工作组
Blood. 1997 Apr 1;89(7):2311-8.
5
The impact of early intensive therapy on event-free survival (EFS) in children with acute myeloid leukemia (AML).早期强化治疗对急性髓系白血病（AML）患儿无事件生存期（EFS）的影响。
Leukemia. 1992;6 Suppl 2:52-4.
6
Remission induction therapy: the more intensive the better?缓解诱导疗法：强度越高越好？
Cancer Chemother Pharmacol. 2001 Aug;48 Suppl 1:S41-4. doi: 10.1007/s002800100305.
7
Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients.初发急性髓系白血病且伴有复杂核型异常的患者，即便接受强化治疗，预后仍较差：一项针对90例患者的研究。
Br J Haematol. 2001 Jan;112(1):118-26. doi: 10.1046/j.1365-2141.2001.02511.x.
8
Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group.米托蒽醌与柔红霉素用于诱导巩固化疗——小剂量阿糖胞苷对维持缓解的价值以及老年急性髓系白血病预后因素评估：最终报告。欧洲癌症研究与治疗组织及荷兰 - 比利时血液肿瘤协作组霍冯小组
J Clin Oncol. 1998 Mar;16(3):872-81. doi: 10.1200/JCO.1998.16.3.872.
9
Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group.自体骨髓移植与强化巩固化疗治疗儿童急性髓细胞白血病。儿科肿瘤学组。
N Engl J Med. 1996 May 30;334(22):1428-34. doi: 10.1056/NEJM199605303342203.
10
Intensive consolidation chemotherapy versus standard consolidation maintenance in acute myelogenous leukemia (AML) in first remission. An EORTC/GIMEMA phase III trial (AML8 B). The EORTC Leukemia Cooperative Group and the GIMEMA Group.急性髓系白血病（AML）首次缓解期强化巩固化疗与标准巩固维持治疗的比较。一项欧洲癌症研究与治疗组织（EORTC）/意大利成人白血病研究组（GIMEMA）的III期试验（AML8 B）。EORTC白血病协作组和GIMEMA组
Leukemia. 1992;6 Suppl 2:76-7.

引用本文的文献

1
Applicability of Western protocols in resource-limited setting: Real-world data of long-term outcome of intensive treatment of adult acute myeloid leukaemia in Sri Lanka.西方方案在资源有限环境中的适用性：斯里兰卡成人急性髓系白血病强化治疗长期结果的真实世界数据。
EJHaem. 2021 May 13;2(3):555-561. doi: 10.1002/jha2.191. eCollection 2021 Aug.
2
Outcomes of intensification of induction chemotherapy for children with high-risk acute myeloid leukemia: A report from the Children's Oncology Group.高危急性髓系白血病患儿强化诱导化疗的结果：来自儿童肿瘤协作组的报告。
Pediatr Blood Cancer. 2021 Dec;68(12):e29281. doi: 10.1002/pbc.29281. Epub 2021 Oct 1.
3
The long shadow of socioeconomic deprivation over the modern management of acute myeloid leukemia: time to unravel the challenges.
社会经济剥夺对急性髓系白血病现代治疗的长期影响：是时候认清这些挑战了。
Blood Cancer J. 2021 Aug 6;11(8):141. doi: 10.1038/s41408-021-00533-0.
4
The blind men and the AML elephant: can we feel the progress?盲人摸象与急性髓系白血病：我们能感受到进展吗？
Blood Cancer J. 2016 May 13;6(5):e424. doi: 10.1038/bcj.2016.33.
5
Is cytotoxic chemotherapy for lymphoma currently feasible for patients in Malawi? A debate.对于马拉维的淋巴瘤患者而言，细胞毒性化疗目前是否可行？一场辩论。
Malawi Med J. 2008 Dec;20(4):120-3. doi: 10.4314/mmj.v20i4.10979.
6
Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials.异基因外周血干细胞与骨髓移植治疗血液系统恶性肿瘤的比较：九项随机试验的个体患者数据荟萃分析
J Clin Oncol. 2005 Aug 1;23(22):5074-87. doi: 10.1200/JCO.2005.09.020.